4//SEC Filing
TOBIN JAMES R 4
Accession 0000950170-24-026472
CIK 0001756262other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:16 PM ET
Size
13.3 KB
Accession
0000950170-24-026472
Insider Transaction Report
Form 4
TOBIN JAMES R
Director
Transactions
- Sale
Common Stock
2024-03-01$81.41/sh−200$16,282→ 233,391 total(indirect: By Trust) - Sale
Common Stock
2024-03-01$82.84/sh−4,234$350,745→ 229,157 total(indirect: By Trust) - Sale
Common Stock
2024-03-01$83.63/sh−5,746$480,538→ 223,411 total(indirect: By Trust) - Sale
Common Stock
2024-03-01$84.74/sh−2,900$245,746→ 220,511 total(indirect: By Trust) - Sale
Common Stock
2024-03-01$85.48/sh−300$25,644→ 220,211 total(indirect: By Trust)
Holdings
- 1,193
Common Stock
Footnotes (5)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 21, 2023.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $82.25 to $83.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $83.26 to $84.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $84.28 to $85.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $85.39 to $85.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
TransMedics Group, Inc.
CIK 0001756262
Entity typeother
Related Parties
1- filerCIK 0001190128
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 6:16 PM ET
- Size
- 13.3 KB